CARBINOXAMINE MALEATE

CARBINOXAMINE MALEATE was reported 193 times

CARBINOXAMINE MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LID LAG 1 0.0143
1 PHLEBITIS INFECTIVE 1 0.0139
2 SUDDEN INFANT DEATH SYNDROME 4 0.0081
3 OROPHARYNGEAL OEDEMA 1 0.0069
4 NASAL ODOUR 1 0.0060
5 ORAL CONTUSION 1 0.0043
6 CHILD ABUSE 1 0.0039
7 ONYCHOPHAGIA 1 0.0036
8 ANOXIC ENCEPHALOPATHY 2 0.0031
9 MULTIPLE SYSTEM ATROPHY 1 0.0028
10 DEATH OF RELATIVE 1 0.0025
11 VIRAL RASH 1 0.0025
12 SCHIZOAFFECTIVE DISORDER 4 0.0022
13 HERNIA PAIN 1 0.0022
14 VITREOUS DISORDER 1 0.0021
15 TOBACCO ABUSE 1 0.0019
16 FRACTURE PAIN 1 0.0019
17 MENTAL DISABILITY 1 0.0017
18 VICTIM OF HOMICIDE 1 0.0017
19 OTORRHOEA 3 0.0017
20 ENDOSCOPY 1 0.0017
21 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
22 ALLERGIC SINUSITIS 1 0.0012
23 INFUSION SITE DISCOLOURATION 1 0.0011
24 UPPER AIRWAY OBSTRUCTION 1 0.0011
25 HYPERVIGILANCE 1 0.0010
26 DRUG TOXICITY 14 0.0010
27 OROPHARYNGEAL SWELLING 1 0.0010
28 SKIN OEDEMA 1 0.0010
29 PNEUMONIA VIRAL 3 0.0009
30 POST PROCEDURAL SWELLING 1 0.0009
31 INTRUSIVE THOUGHTS 1 0.0008
32 OTITIS EXTERNA 1 0.0008
33 GLUCOSE URINE PRESENT 1 0.0008
34 LIP INJURY 1 0.0008
35 COCCYDYNIA 1 0.0007
36 TONGUE COATED 1 0.0006
37 APPENDICECTOMY 2 0.0006
38 DISORGANISED SPEECH 1 0.0005
39 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
40 BREAST DISORDER 1 0.0005
41 INFUSION SITE BRUISING 1 0.0005
42 MIDDLE EAR EFFUSION 1 0.0005
43 WRONG DRUG ADMINISTERED 4 0.0004
44 SPINAL COLUMN INJURY 1 0.0004
45 FEAR OF DEATH 1 0.0004
46 ORAL PRURITUS 1 0.0004
47 PERSECUTORY DELUSION 1 0.0004
48 EXCORIATION 1 0.0004
49 HOSTILITY 1 0.0004
50 APPENDICITIS PERFORATED 1 0.0004
51 DRUG SCREEN POSITIVE 3 0.0004
52 PULMONARY CONGESTION 5 0.0004
53 ANGIONEUROTIC OEDEMA 1 0.0004
54 PHARYNGITIS STREPTOCOCCAL 4 0.0004
55 STREPTOCOCCAL INFECTION 2 0.0004
56 LUMBAR SPINAL STENOSIS 1 0.0003
57 NECK INJURY 1 0.0003
58 SCOLIOSIS 2 0.0003
59 BLOOD CREATININE DECREASED 1 0.0003
60 INFUSION SITE PRURITUS 1 0.0003
61 OEDEMA MOUTH 1 0.0003
62 BREAST ENLARGEMENT 1 0.0003
63 OTITIS MEDIA 1 0.0003
64 BREAST MASS 2 0.0003
65 HYPERREFLEXIA 1 0.0003
66 PARADOXICAL DRUG REACTION 1 0.0003
67 UNRESPONSIVE TO STIMULI 7 0.0003
68 CHRONIC SINUSITIS 1 0.0003
69 TONGUE OEDEMA 1 0.0003
70 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
71 CONCUSSION 2 0.0003
72 RHINOVIRUS INFECTION 1 0.0003
73 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
74 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
75 DRUG LEVEL INCREASED 4 0.0002
76 HYSTERECTOMY 2 0.0002
77 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
78 INJECTION SITE PAPULE 1 0.0002
79 LUMBAR VERTEBRAL FRACTURE 1 0.0002
80 VEIN DISORDER 1 0.0002
81 DRUG TOLERANCE 1 0.0002
82 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
83 HEREDITARY ANGIOEDEMA 2 0.0002
84 INTESTINAL RESECTION 1 0.0002
85 BIPOLAR DISORDER 2 0.0002
86 NEUROLOGICAL SYMPTOM 1 0.0002
87 INFUSION SITE EXTRAVASATION 1 0.0002
88 INFUSION SITE SWELLING 1 0.0002
89 SCREAMING 1 0.0002
90 TENDON DISORDER 1 0.0002
91 ORAL CANDIDIASIS 2 0.0002
92 EYE MOVEMENT DISORDER 1 0.0001
93 SEASONAL ALLERGY 2 0.0001
94 HAND FRACTURE 1 0.0001
95 INTENTIONAL DOSE OMISSION 4 0.0001
96 PRODUCT SUPPLY ISSUE 1 0.0001
97 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
98 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
99 INSURANCE ISSUE 2 0.0001
100 RENAL FAILURE CHRONIC 1 0.0001
101 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
102 RHINITIS 1 0.0001
103 SENSATION OF FOREIGN BODY 1 0.0001
104 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
105 SKIN SWELLING 1 0.0001
106 HEAD DISCOMFORT 2 0.0001
107 HAEMARTHROSIS 1 0.0001
108 OROPHARYNGEAL DISCOMFORT 1 0.0001
109 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
110 CONJUNCTIVITIS 2 0.0001
111 PERSONALITY CHANGE 1 0.0001
112 HEPATIC STEATOSIS 2 0.0001
113 FEELING JITTERY 2 0.0001
114 SLEEP APNOEA SYNDROME 2 0.0001
115 SINUS BRADYCARDIA 1 0.0001
116 EAR PAIN 2 0.0001
117 SKIN FISSURES 2 0.0001
118 PHARYNGEAL SWELLING 1 0.0001
119 COELIAC DISEASE 1 0.0001
120 KNEE OPERATION 1 0.0001
121 SUBARACHNOID HAEMORRHAGE 1 0.0001
122 SINUSITIS 10 0.0001
123 RIB FRACTURE 2 0.0001
124 PETECHIAE 1 0.0001
125 BLOOD CALCIUM DECREASED 1 0.0001
126 EYE INFECTION 1 0.0001
127 REBOUND EFFECT 1 0.0001
128 IMPAIRED DRIVING ABILITY 1 0.0001
129 SPINAL PAIN 1 0.0001
130 BACTERAEMIA 1 0.0001
131 WRIST FRACTURE 1 0.0001
132 INJECTION SITE URTICARIA 2 0.0001
133 SPINAL OPERATION 1 0.0001
134 EYE SWELLING 3 0.0001
135 INJECTION SITE DISCOLOURATION 1 0.0001
136 INFUSION SITE PAIN 1 0.0001
137 JOINT STIFFNESS 2 0.0001
138 JOINT RANGE OF MOTION DECREASED 1 0.0001
139 ABNORMAL DREAMS 2 0.0001
140 PROCEDURAL PAIN 2 0.0001
141 POLLAKIURIA 3 0.0001
142 BRONCHOSPASM 1 0.0001
143 HYPERSOMNIA 2 0.0001
144 IMPAIRED QUALITY OF LIFE 1 0.0001
145 SKIN HAEMORRHAGE 1 0.0001
146 PULMONARY MASS 1 0.0001
147 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
148 MUSCULOSKELETAL CHEST PAIN 1 0.0001
149 HALLUCINATION, AUDITORY 1 0.0001
150 PRODUCTIVE COUGH 3 0.0001
151 OBESITY 1 0.0001
152 MOOD SWINGS 2 0.0001
153 BACK DISORDER 1 0.0001
154 MULTIPLE FRACTURES 1 0.0001
155 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
156 EYE PRURITUS 2 0.0001
157 TYPE 2 DIABETES MELLITUS 2 0.0001
158 AGITATION 4 0.0001
159 ARTHROPATHY 3 0.0001
160 MIDDLE INSOMNIA 1 0.0001
161 PROTEINURIA 1 0.0001
162 EYE IRRITATION 3 0.0001
163 LOWER LIMB FRACTURE 1 0.0001
164 HERNIA 1 0.0001
165 CHOKING 1 0.0001
166 SINUS DISORDER 1 0.0001
167 PREGNANCY 1 0.0000
168 PRODUCT ADMINISTRATION ERROR 1 0.0000
169 INJECTION SITE WARMTH 1 0.0000
170 URTICARIA 8 0.0000
171 DERMATITIS 1 0.0000
172 LOSS OF CONSCIOUSNESS 6 0.0000
173 POOR QUALITY SLEEP 1 0.0000
174 PRODUCT PRESCRIBING ISSUE 1 0.0000
175 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
176 HEPATOTOXICITY 1 0.0000
177 HEART RATE IRREGULAR 1 0.0000
178 PERICARDIAL EFFUSION 1 0.0000
179 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
180 OCULAR HYPERAEMIA 2 0.0000
181 LOCALISED INFECTION 1 0.0000
182 FIBROMYALGIA 1 0.0000
183 BRONCHITIS 3 0.0000
184 AGGRESSION 2 0.0000
185 GASTRIC CANCER 1 0.0000
186 HAEMATEMESIS 1 0.0000
187 FLUID RETENTION 2 0.0000
188 DIPLOPIA 1 0.0000
189 RESPIRATORY TRACT INFECTION 1 0.0000
190 NERVOUSNESS 2 0.0000
191 ECZEMA 2 0.0000
192 SEDATION 1 0.0000
193 ARTHRITIS 3 0.0000
194 DERMATITIS ATOPIC 2 0.0000
195 EAR INFECTION 1 0.0000
196 THROAT TIGHTNESS 1 0.0000
197 RASH PRURITIC 2 0.0000
198 LIMB INJURY 1 0.0000
199 PNEUMONITIS 1 0.0000
200 MOOD ALTERED 1 0.0000
201 ANAPHYLACTIC REACTION 2 0.0000
202 MENTAL STATUS CHANGES 1 0.0000
203 WOUND 1 0.0000
204 PAIN IN JAW 1 0.0000
205 SOMNOLENCE 7 0.0000
206 LETHARGY 2 0.0000
207 SURGERY 2 0.0000
208 ACUTE MYOCARDIAL INFARCTION 1 0.0000
209 PSYCHOTIC DISORDER 1 0.0000
210 WHEEZING 2 0.0000
211 IRRITABILITY 2 0.0000
212 PREMATURE BABY 1 0.0000
213 LACRIMATION INCREASED 1 0.0000
214 EPILEPSY 1 0.0000
215 INJECTION SITE RASH 1 0.0000
216 DRUG ADMINISTRATION ERROR 1 0.0000
217 CHEST PAIN 6 0.0000
218 HYPERSENSITIVITY 6 0.0000
219 INJECTION SITE ERYTHEMA 4 0.0000
220 BONE DENSITY DECREASED 1 0.0000
221 HEAD INJURY 1 0.0000
222 HYPOTHYROIDISM 1 0.0000
223 CONTUSION 3 0.0000
224 DEEP VEIN THROMBOSIS 2 0.0000
225 SWELLING FACE 2 0.0000
226 STAPHYLOCOCCAL INFECTION 1 0.0000
227 INFUSION RELATED REACTION 2 0.0000
228 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
229 VIRAL INFECTION 1 0.0000
230 LIP SWELLING 1 0.0000
231 URINARY RETENTION 1 0.0000
232 ANGER 1 0.0000
233 SLEEP DISORDER 2 0.0000
234 THERAPY INTERRUPTED 2 0.0000
235 CRYING 1 0.0000
236 PANIC ATTACK 1 0.0000
237 RESTLESSNESS 1 0.0000
238 DYSARTHRIA 1 0.0000
239 DYSPNOEA EXERTIONAL 1 0.0000
240 ASTHMA 3 0.0000
241 MUSCULAR WEAKNESS 3 0.0000
242 INJECTION SITE SWELLING 2 0.0000
243 PYREXIA 9 0.0000
244 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
245 ABNORMAL BEHAVIOUR 1 0.0000
246 DISORIENTATION 1 0.0000
247 DRUG INTERACTION 4 0.0000
248 COUGH 7 0.0000
249 DYSKINESIA 1 0.0000
250 OSTEOPOROSIS 1 0.0000
251 CARDIO-RESPIRATORY ARREST 1 0.0000
252 PRODUCT DOSE OMISSION ISSUE 7 0.0000
253 OSTEOARTHRITIS 1 0.0000
254 RENAL FAILURE ACUTE 1 0.0000
255 PRURITUS 9 0.0000
256 PSORIASIS 3 0.0000
257 INSOMNIA 6 0.0000
258 TACHYCARDIA 2 0.0000
259 HEADACHE 14 0.0000
260 ADVERSE DRUG REACTION 2 0.0000
261 THERAPY NON-RESPONDER 1 0.0000
262 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
263 DEPRESSION 5 0.0000
264 VISION BLURRED 3 0.0000
265 SUICIDAL IDEATION 2 0.0000
266 TINNITUS 1 0.0000
267 NASOPHARYNGITIS 4 0.0000
268 OROPHARYNGEAL PAIN 2 0.0000
269 BLOOD CHOLESTEROL INCREASED 1 0.0000
270 COGNITIVE DISORDER 1 0.0000
271 ARRHYTHMIA 1 0.0000
272 ANXIETY 6 0.0000
273 PULMONARY EMBOLISM 2 0.0000
274 MIGRAINE 2 0.0000
275 INFECTION 3 0.0000
276 INTERSTITIAL LUNG DISEASE 1 0.0000
277 ATRIAL FIBRILLATION 2 0.0000
278 HEART RATE INCREASED 2 0.0000
279 SYNCOPE 2 0.0000
280 CHEST DISCOMFORT 2 0.0000
281 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
282 MUSCULOSKELETAL PAIN 1 0.0000
283 PANCREATITIS 1 0.0000
284 OEDEMA 1 0.0000
285 INFLUENZA 2 0.0000
286 NECK PAIN 1 0.0000
287 PANCYTOPENIA 1 0.0000
288 HYPONATRAEMIA 1 0.0000
289 EYE PAIN 1 0.0000
290 FLATULENCE 1 0.0000
291 URINARY TRACT INFECTION 3 0.0000
292 CONVULSION 1 0.0000
293 SEIZURE 2 0.0000
294 DYSPHONIA 1 0.0000
295 PALPITATIONS 2 0.0000
296 BONE PAIN 1 0.0000
297 CHILLS 2 0.0000
298 ILL-DEFINED DISORDER 1 0.0000
299 VERTIGO 1 0.0000
300 DISCOMFORT 1 0.0000
301 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
302 VISUAL IMPAIRMENT 2 0.0000
303 RASH 7 0.0000
304 BLOOD PRESSURE DECREASED 1 0.0000
305 FALL 5 0.0000
306 DEHYDRATION 2 0.0000
307 DRY SKIN 2 0.0000
308 INJECTION SITE PRURITUS 1 0.0000
309 VOMITING 7 0.0000
310 PAIN 9 0.0000
311 MEMORY IMPAIRMENT 2 0.0000
312 ARTHRALGIA 6 0.0000
313 INJURY 1 0.0000
314 HYPERTENSION 3 0.0000
315 DIZZINESS 7 0.0000
316 DYSGEUSIA 1 0.0000
317 WEIGHT INCREASED 3 0.0000
318 ASTHENIA 5 0.0000
319 HALLUCINATION 1 0.0000
320 UNEVALUABLE EVENT 1 0.0000
321 CHRONIC KIDNEY DISEASE 1 0.0000
322 INCORRECT DOSE ADMINISTERED 3 0.0000
323 DIABETES MELLITUS 1 0.0000
324 INJECTION SITE PAIN 4 0.0000
325 HOSPITALISATION 2 0.0000
326 INJECTION SITE HAEMORRHAGE 1 0.0000
327 CARDIAC FAILURE CONGESTIVE 1 0.0000
328 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
329 CONFUSIONAL STATE 2 0.0000
330 PNEUMONIA 4 0.0000
331 DRY MOUTH 1 0.0000
332 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
333 DRUG INEFFECTIVE 16 0.0000
334 DRUG ABUSE 1 0.0000
335 ABDOMINAL DISCOMFORT 2 0.0000
336 SKIN EXFOLIATION 1 0.0000
337 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
338 COVID-19 2 0.0000
339 NO ADVERSE EVENT 2 0.0000
340 MUSCLE SPASMS 2 0.0000
341 DYSPHAGIA 1 0.0000
342 NEUROPATHY PERIPHERAL 1 0.0000
343 FATIGUE 8 0.0000
344 PAIN IN EXTREMITY 3 0.0000
345 DYSPEPSIA 1 0.0000
346 CONDITION AGGRAVATED 3 0.0000
347 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
348 HAEMOGLOBIN DECREASED 1 0.0000
349 ILLNESS 1 0.0000
350 HAEMORRHAGE 1 0.0000
351 CONSTIPATION 2 0.0000
352 SEPSIS 1 0.0000
353 THROMBOCYTOPENIA 1 0.0000
354 DECREASED APPETITE 2 0.0000
355 ABDOMINAL PAIN 2 0.0000
356 FEELING ABNORMAL 2 0.0000
357 JOINT SWELLING 1 0.0000
358 OEDEMA PERIPHERAL 1 0.0000
359 HYPERHIDROSIS 1 0.0000
360 NAUSEA 6 0.0000
361 WEIGHT DECREASED 2 0.0000
362 DYSPNOEA 4 0.0000
363 OFF LABEL USE 6 0.0000
364 HYPOAESTHESIA 1 0.0000
365 BLOOD PRESSURE INCREASED 1 0.0000
366 PERIPHERAL SWELLING 1 0.0000
367 PARAESTHESIA 1 0.0000
368 DIARRHOEA 4 0.0000
369 TREMOR 1 0.0000
370 MYALGIA 1 0.0000
371 PRODUCT USE ISSUE 1 0.0000
372 BLOOD GLUCOSE INCREASED 1 0.0000
373 HYPOTENSION 1 0.0000
374 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
375 ABDOMINAL PAIN UPPER 1 0.0000
376 MALAISE 2 0.0000
377 DEATH 3 0.0000